Chile's Institute of Public Health said on Thursday it had approved the emergency use of COVID-19 vaccine developed by Belgian laboratory Janssen for U.S. pharmaceutical Johnson & Johnson (JNJ.N).
A vial of the Johnson & Johnson's coronavirus disease vaccine is seen at Northwell Health's South Shore University Hospital in Bay Shore, New York, U.S., March 3, 2021. REUTERS/Shannon Stapleton
"This vaccine, which requires a single dose, is already authorized in Brazil, the United Kingdom, Canada, Colombia, the European Union, Mexico and the United States, in people aged 18 years and over," the institute said in a statement. Earlier Thursday, European Union decided not to take up an option to buy 100 million doses of J&J's vaccine after reports of safety and supply problems. The vaccine has been linked to very rare but serious cases of blood clots.The GAVI Vaccine Alliance said late last month it has agreed to buy 200 million doses of J&J's vaccine as it sought to fill a shortfall in COVAX provision caused by India suspending exports.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Many Johnson & Johnson COVID-19 vaccine doses may be close to expiringThe buildup of unused doses is a result of safety concerns after the FDA paused distribution of the J&J doses, state health officials say.
Read more »
Biden and Johnson expected to commit to lifting US-UK Covid-19 travel restrictionsCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Read more »
India data revision results in world’s highest daily Covid-19 death tollMany experts believe India’s death toll is several times higher than the official number. The previous world record was 5,527 in the US on February 12, also due to an upwards revision of earlier deaths.
Read more »
U.S. to Donate 500 Million Covid-19 Vaccine Doses to Lower-Income CountriesThe Biden administration expects 200 million Pfizer doses will go to other countries this year and 300 million more across the first half of 2022. They will be donated through the Covax global initiative.
Read more »
Covid-19: 'Our wedding changed more times than I can count'Couples set to get married and the wedding industry face an anxious wait for restrictions to ease.
Read more »
Ocugen to file for full U.S. approval of COVID-19 shot instead of EUAOcugen Inc (OCGN.O) said on Thursday it would no longer pursue an emergency use authorization for its COVID-19 vaccine candidate, Covaxin, and would instead aim to file for a full U.S. approval of the shot.
Read more »